Johnson & Johnson ordered to pay $18.8 million in California Talc-Cancer trial. Details here
Also read: Johnson & Johnson proposes nearly $9 billion settlement of talc cancer claims The $18.8 million award to Valadez could complicate J&J's efforts to convince other talc victims to accept an $8.9 billion settlement offered as part of the bankruptcy case filed by its LTL Management unit. This settlement was intended to cover all existing and future lawsuits alleging that J&J knowingly sold talc-based baby powder containing asbestos.
Also read: Bombay HC permits Johnson & Johnson to manufacture and sell its baby powder According to Carl Tobias, a University of Richmond law professor who teaches about mass torts, the verdict could sway other plaintiffs not to accept the settlement, as they might see greater potential for compensation through individual trials. This development could disrupt settlement negotiations for J&J.
As a result of slipping sales, Johnson & Johnson pulled its talc-based powders from the US and Canada markets in 2020, replacing them with a corn-starch-based version. The company has committed to removing all talcum powder-containing baby powders from the global market by the end of this year.
Read more on livemint.com
